System Formulary Update
Denosumab-bbdz (Wyost) 120 mg/1.7 mL (70 mg/mL) SDV
December 9, 2025
Situation
Denosumab-bbdz (Wyost) 120 mg/1.7 mL (70 mg/mL) SDV was approved for addition to the UNC Health system formulary by the Executive Pharmacy and Therapeutics group in November 2025.
Background
The following medication was reviewed: Denosumab-bbdz (Wyost) 120 mg/1.7 mL (70 mg/mL) SDV
Assessment/Recommendation
Change effective: Tuesday, December 16, 2025